orglex.com
Jul 13, 2008
Commonwealth Biotechnologies (CBTE) and Venturepharm Laboratories tightened up their relationship as Commonwealth exercised a $1 million put option with Venturepharm. Under the terms of the deal, Commonwealth sold 463,426 shares of common stock to Venturepharm at $2.15 per share, a 56% premium to the June 30, 2008 share price of [...] [ Seeking Alpha ] -...
[read full story]